AHA Coding Clinic® for HCPCS - 2013 Issue 2
Reporting drugs and biologicals
The Central Office on HCPCS frequently receives requests for coding assistance pertaining to the correct reporting of drugs and biologicals that fall under HCPCS Level II J-codes. Based on the volume of these requests, we have decided to review some basic guidelines to assist in reporting these codes. CMS has instructed that hospitals should report all appropriate HCPCS codes and charges for separately reportable drugs, in addition to reporting the applicable drug administration codes. Hospitals also are required to report the HCPCS codes and charges for drugs that are packaged into payments for the corresponding drug administration or other...
Subscribe or sign in to view the full article.
Article Overview
This article explains general HCPCS Level II reporting guidance for drugs and biologicals in the hospital setting. It addresses how quantities are reported, how compounded or unlisted products may be handled, how discarded amounts are treated, and what related Medicare resources are referenced. It is intended for billing, coding, and reimbursement staff who work with drug and biological claims.
Why This Topic Matters
Accurate reporting of drugs and biologicals affects claim completeness, payment, and compliance for hospitals and other providers. The article helps readers understand the broad categories of guidance that can influence how these services are captured and billed.
Article Sections
-
Reporting drugs and biologicals under HCPCS Level II
Overview of general reporting issues for drugs and biologicals, including hospital billing context and HCPCS Level II guidance.
-
Units administered
Discussion of how reported quantities relate to administered amounts and how dosage descriptors affect billing units.
-
“Up To” code descriptor
General treatment of codes with quantity language that uses an upper limit and how those descriptors are addressed.
-
Compounded drugs
Broad guidance on compounded products, unlisted drug reporting, and situations involving drugs without a specific HCPCS assignment.
-
Discarded drugs and biologicals
General discussion of discarded amounts from single-use packaging, modifier usage, and related Medicare considerations.
What You Will Learn
- How the article frames HCPCS Level II reporting for drugs and biologicals
- What general topics are covered for administered quantities and dosage descriptors
- How the article approaches compounded and unlisted drug situations
- What broad guidance is provided about discarded drugs and biologicals
- Which referenced organizations and Medicare materials are mentioned
Who Should Read This
- Hospital coding staff
- Billing and reimbursement teams
- Revenue cycle professionals
- Compliance staff
- Health information management professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com